| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Fundraising > Three Donor Newsletter Mistakes to Avoid in Direct Mail Fundraising |
|
Main Subject - Three Donor Newsletter Mistakes to Avoid in Direct Mail Fundraising
Every healthy direct mail fundraising program
balances asking with informing. Appeal letters do the
asking. And donor newsletters According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product do the informing.
But your donors will only read your newsletters if each newsletter is donor-centered and engaging. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in You can’t simply present news. Instead, you must
write every issue with your donor in mind. To do
that, avoid these three common lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. mistakes in donor
fundraising newsletters. Mistake #1: Focus on the institution, not the donor.br> If your news here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe etters are filled with stories about board
member retreats, staff appointments and promotions
and accounts of what goes on at hea d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d office, you
are writing about yourselves. And donors don’t want
to read about you. They want to read about
themselves, and th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e things that interest them. So
before you touch a key on your keyboard, ask
yourself if the story you are about to publish in yo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ur
newsletter is about you or about your
donors. Mistake #2: Clich? photos. You’ve seen them. The staff and nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically olunteers standing
behind an oversized cheque. Or the mayor cutting a
ribbon in front of the new library. Or a bunch of men
in and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ suits, wearing hardhats and holding shovels,
bending over and grinning as they pretend to break
ground for a new building. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi > These photos are so tired and overused that city newspaper editors hate them. So avoid them in your donor newsletters. Instead ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a , capture your staff,
volunteers and donors doing something original. Only
publish newsletter photos that tell your story in
cr dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ative ways. Mistake #3: No captions under photos. A picture is never worth a thousand words. Would you buy a h cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ouse from a photo only, however
informative? Would you take a new job if all you had
to go on was a terrific photo of the person tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen who is in
the role presently? Just about every photo you publish in your newsletter requires explaining. Why is that ta t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ll man
chained to the railing of the US embassy? Who is
that boy receiving that gift? Where in the world was
this photo taken? ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hen did this event take place?
Answer these questions that your photos evoke by
captioning every photo. Think who, what, why,
w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products here, when and how. Learn more abour how to write and design effective newsletters by reading Handbook 15 in the popular . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Hands-on Fundraising Series published by Andrew
Spencer Publishing: elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip 15-donor-centered-newsletter-stories.htm">Increase
Your Income and Boost Donor Loyalty with
Donor-Centered Newsletter Stories tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Apply For Government Grants Or You Will Regret Entrepreneurs, Fear of Success and the Myth of Commonality
|